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Abstract
Background: It has been reported that bifocal pacing (BiF) in the right ventricle might be an
alternative to unsuccessful left ventricular lead implantation. This case report presents an
assessment of the clinical and hemodynamic parameters during a three month follow-up in
patients implanted with right ventricular BiF.
Methods: Eight patients who underwent unsuccessful left ventricular lead implantation were
implanted with a bifocal system in the right ventricular. Leads were implanted in the right
atrium appendage, the apex and the right ventricular outflow tract and connected to the
cardiac resynchronization therapy pacemaker. All patients performed a sixminute walking test
and underwent echocardiography after the implantation and after the three month follow-up.
Results: We found a significant performance increase in the six minute walking test and
reduction in New York Heart Association class and mitral regurgitation in echocardiography
study, as well as a significant increase in left ventricular ejection fraction, and cardiac output
directly after the implantation, as well as at threemonth follow-up in patients after BiF im-
plantation.
Conclusions: Right ventricular bifocal pacing in patients with cardiac resynchronization
therapy indication and unsuccessful left ventricular lead placement seems to be a beneficial
treatment for heart failure. Satisfactory hemodynamic and clinical results were observed
directly after BiF implantation and during the three month follow-up. (Cardiol J 2010; 17, 1:
35–41)
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Introduction
Biventricular pacing has proven beneficial for
patients with congestive heart failure in New York
Heart Association (NYHA) functional classes III–IV,
a bundle branch block with a QRS duration > 120 ms
and a reduced left ventricular ejection fraction
(LVEF) [1–4].
Despite continuous progress in left ventricu-
lar implantation technology, a completely success-
ful biventricular pacemaker (BiV) implantation rate
has not been achieved. Published data has shown
a 6–12% rate of failed left ventricular lead insertion
[5, 6]. Furthermore, these studies demonstrated
that, if pacing at the target site (left or posterior
veins) was not achievable, alternative pacing ves-
sels (e.g. an anterior vein) should be used. More-
over, left ventricular lead placement has a relative-
ly high (7–14%) risk of early and late dislodgement
[7, 8]. Further complications linked to cardiac re-
synchronization include phrenic nerve stimulation
and pocket infection [8]. A transthoracic epicardial
approach may be an alternative for failed trans-
venous left ventricle implantation. Unfortunately,
this method may be associated with some compli-
cations [9, 10]. Other methods for cardiac resyn-
chronization therapy (CRT) implantation have been
recently reported [11–14], but there is little pub-
lished data so far. Some recently published studies
show that right ventricular bifocal pacing (BiF) may
be a feasible alternative to CRT [15–19]. First stud-
ies with BiF treatment patients with heart failure
were published in nineteen years. However, it is
one of the first published results of BiF in the end
stage heart failure patients (in NYHA IV) with long
term follow up.
The aim of our study was to assess clinical and
hemodynamic parameters during a three month
follow-up in patients with end-stage heart failure,
implanted with BiF in the right ventricle in which
standard transvenous BiV procedures were found
to be ineffective or unsatisfactory.
Methods
The study was a single center study. Consec-
utive patients with CRT indications and unsuccess-
ful left ventricular lead implantation were enrolled
into this study. Inclusion criteria were as follows:
NYHA functional class III or IV despite optimal
management, LVEF < 40%, ventricular dyssyn-
chrony defined as interventricular mechanical delay
> 40 ms, sinus rhythm, QRS duration of > 120 ms
due to left bundle branch block.
The implantation procedure
Access to the coronary sinus (CS) for left ven-
tricular lead placement (Biotronik Corox LV-H 75-UP,
used in every patient) was achieved either by us-
ing the Biotronik Introducer — Scout –8 F or di-
rectly via a stylet. A pacing site was considered
satisfactory if the pacing threshold was below 5 V
(0.5 ms width) with the absence of diaphragmatic
stimulation at 10 V (0.5 ms width). If these criteria
were not met, after a left lead dislodgement hap-
pened three times, or a fluoroscopy duration of more
than 40 minutes, the patients underwent implanta-
tion of bifocal right ventricular leads. The screw-in
endocardial lead (Biotronik Elox P) to the right ven-
tricular outflow tract (RVOT) was defined accord-
ing to Lieberman’s rules [20]. To help differentiate
the RVOT septum and free wall — the left oblique
— and in determining high and low position right
oblique, 40 degree fluoroscopic was used. A passive
fixation lead (Biotronik Synox 60-BP) to the right
ventricular apex was implanted in each patient. The
third lead (Synox 53-JBP) was placed in the right
atrial appendage. The Stratos left ventricular pace-
maker was implanted in all patients.
The apical lead was connected to the right ven-
tricle and the RVOT lead to the left ventricle port.
The atrial lead was connected to the pacemaker’s
atrial channel.
Study protocol
All the patients performed a six minute walking
test (6MWT) and underwent echocardiography before
and after the pacemaker implantation (between the
second and sixth days, mean 4.2 ± 3) and at the
three month follow-up. NYHA functional class was
evaluated before, and three months after, the BiF
implantation. A 12-lead surface electrocardiogram
(ECG) was done on all patients in the supine position
before and after implantation in order to assess the
QRS duration. All the ECGs were recorded at a pa-
per speed of 100 mm/s and 4 mV/cm standarization.
Hemodynamic parameters were assessed be-
fore and after implantation by echocardiography,
performed using Hewlett Packard Sonos 5500 be-
fore the implantation. The following parameters
were evaluated: left ventricular end-diastolic diam-
eter (LVDD) [mm]; left ventricular end-systolic
diameter (LVSD) [mm], LVEF by Simpsons’s meth-
od (%), cardiac output (CO) [l/min] and degree of
mitral valve regurgitation.
The optimal atrioventricular (AV) delay was
programmed according to the Ritter method [21].
DDD 70 beats/min mode with RVOT/RVA with
5 ms delay was programmed in all the patients.
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Pharmacotherapy remained unchanged thro-
ughout the study.
The study was approved by the local bioethical com-
mittee and all patients gave their informed consent.
Statistical analysis
All numerical variables are reported as means
± standard deviation. Continuous variables were
compared using a two-sided t-Student’s test.
P-values < 0.05 were considered significant.
Results
The left ventricular lead placement was not
successful in eight patients (13%) out of the total
60 patient population with criteria for CRT implan-
tation. This group of eight was implanted with the
BiF system. The reasons for changing from the BiV
to the BiF system were as follows: in one patient
CS occlusion; in two patients an unacceptable pac-
ing threshold (> 5.0 V; 0.5 ms width); in one
patient diaphragmatic nerve stimulation; in ano-
ther patient the intraoperative lead was dislodged
three times; and in three patients X-ray exposure
lasted over 40 minutes. The detailed clinical
data of the studied BiF population is presented
in Table 1.
Clinical data assessment
Six minute walking test. A significant in-
crease in walking distance during the 6MWT was
observed in all patients directly after implantation
and at the three month follow-up. During the three
month follow-up, the results from the 6MWT were
even better compared to the results after implan-
tation. However, the differences were not statisti-
cally significant. The results are shown in Figure 1.
NYHA class. The majority (six of the eight)
of the patients were in NYHA class IV heart failure
status. An improvement in the NYHA functional
class status was seen in each patient. Six patients
went from NYHA class IV to class III, and two pa-
tients went from class III to class II.
QRS duration. The mean duration of QRS
complex was wider after implantation (QRS before
179.6 ± 29 vs QRS after 184 ± 46; NS). Only in
three patients was a reduction in QRS duration ob-
served. These results are presented in Figure 2.
Echocardiographic measurements
Echocardiographic evaluation revealed a signif-
icant increase in CO and LVEF after bifocal implan-
tation. No differences were observed in LVDD. The
mitral regurgitation was reduced after BiF, but sig-
nificant differences were found only comparing the
three month follow-up to the pre- and post-implant
Table 1. Baseline characteristics of studied patients.
No. of Age Male NYHA LVEF QRS duration Etiology of
patients class (%)  [ms]  cardiomyopathy
1 52 Yes IV 19 202 Non-ischemic
2 67 Yes IV 25 153 Ischemic
3 54 Yes IV 28 147 Non-ischemic
4 68 No IV 13 175 Non-ischemic
5 45 Yes III 27 159 Ischemic
6 72 Yes IV 18 165 Non-ischemic
7 68 Yes IV 15 224 Non-ischemic
8 69 No III 30 212 Non-ischemic
Mean 61.8 ± 10 Total males: 21.9 ± 6.4 179.6 ± 29 Total non-ischemic
6 (75%) cardiomyopathy: 6 (75%)
NYHA — New York Heart Association, LVEF — left ventricular ejection fraction
Figure 1. Comparison between six minute walking test
(6MWT) before, after and at three month follow-up in
eight patients with bifocal implantation.
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periods. All other echocardiographic parameters
were unchanged during the three month follow-up
compared to the results directly after implantation.
The results are shown in Figures 3–7.
Discussion
Nowadays, left ventricular lead implantation via
a transvenous approach is a widely accepted method
Figure 2. Comparison between QRS duration before
and after right ventricular bifocal implantation in eight
patients; p = non significant (NS).
Figure 3. Left ventricular diastolic diameter (LVDD) befo-
re, after and at three month follow-up in eight patients
with right ventricular bifocal implantation; A vs B: p = NS,
A vs C: p = NS, B vs C: p = NS.
Figure 5. Left ventricular ejection fraction (LVEF) before,
after and at three month follow-up in eight patients with
right ventricular bifocal implantation; A vs B: p < 0.01,
A vs C: p < 0.05, B vs C: p = NS.
Figure 4. Left ventricular systolic diameter (LVSD) before,
after and at three month follow-up in eight patients with
right ventricular bifocal implantation; A vs B: p < 0.05,
A vs C: p < 0.05, B vs C: p = NS.
Figure 6. Cardiac output (CO) before, after and at three
month follow-up in eight patients with right ventricular
bifocal implantation; A vs B: p < 0.05, A vs C: p < 0.05,
B vs C: p = NS.
Figure 7. The mean mitral regurgitation grade (MRG)
before, after and at three month follow-up in eight pa-
tients with right ventricular bifocal implantation; A vs B:
p = NS, A vs C: p < 0.05, B vs C: p < 0.05.
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for CRT. However, this technique, despite con-
tinued progress in the development of implantation
tools, takes rather a long time, requires a high flu-
oroscopic exposure and does not guarantee success
in all cases. Still today, publications on CRT report
procedural failure in 10–20% of patients. The implan-
tation success rate has been reported as follows: 89%
in InSync Italian registry, 82% in EasyTrak Pre CE
Mark Clinical Investigation and 87% in CONTAK regi-
stry [8, 22, 23]. Furthermore, a high percentage of
left ventricular lead dislodgement is still reported:
7.4% in InSync Italian registry [8] and 6% in the
Miracle study [2]. Even in the last year, published
data with modern left ventricular leads is still high:
a 6–8% of dislodgment has been reported [24]. The
dissection or perforation of the coronary sinus dire-
ctly associated with transvenous lead implantation
was the other serious complication found in the
MIRACLE study. This study reported two deaths
related to this procedure.
Published studies prove that the beneficial ef-
fects of CRT are strictly associated with choosing
the correct implantation site. Left ventricular lead
positioning in the ‘anterior veins’ might explain the
number of patients who do not respond to CRT [25,
26]. In the InSync Italian registry, only 71% of left
ventricular leads were placed in the lateral or pos-
terolateral vein [8]. In the EasyTrack Pre-CE Mark,
only 50% of the leads were in the lateral vein [18].
Finally, even experienced cardiologists reported
that the lateral vein was reached only in 80% of
patients (MUSTIC trial) [1].
Furthermore, neither post-implantation QRS
narrowing [27] nor acute hemodynamic response to
CRT [28] proved to be a predictor for the improve-
ment of symptoms and hemodynamic status.
Transvenous implantation procedure has cer-
tainly proved to be feasible, but it is highly depen-
dent on the physician’s level of experience, can last
an unpredictably long time, and occasionally have
severe complications.
Left ventricular epicardial implantation is an
accepted method for CRT in case of an unsuccess-
ful transvenous approach. The first CRT implanta-
tion with thoracotomy under general anaesthesia
caused serious complications [9, 10]. Furthermore,
left ventricular screw-in epicardial lead placement
usually results in a high pacing threshold and loss
of capture [11]. Limited thoracotomy decreases the
number of complications, and the introduction of
steroid eluting epicardial leads reduces the adverse
events reported in previous series [29]. The advan-
tage of this method, compared to transvenous left
ventricular lead implantation, is in minimizing the
length of the procedure, as well as the exposure to
fluoroscopic time, and creating the possibility of
placing the left ventricular lead at an optimal site.
On the other hand, even limited thoracotomy can
be performed only in a cardiosurgery department;
it lengthens the duration of the patient’s hospital
stay and increases the costs of the procedure.
Bifocal stimulation in the right ventricle may
be an alternative to unsuccessful left ventricular
lead implantation. The first data about right ventri-
cular bifocal pacing in five patients with Chagas dis-
ease and permanent atrial fibrillation with complete
AV block was published in 1999 [30]. A significant
increase in LVEF and CO during BiF was report-
ed. Subsequent studies with a larger number of
patients confirmed the previous results [31].
Until now, only a few publications about BiF
have appeared. Kutarski et al. [32, 33] suggested
in studies performed during implantation that BiF
pacing might be beneficial in patients with unsuc-
cessful left ventricular implantation. Vlay et al. [34]
published three cases in 2003 in which BiF decreased
the NYHA class, improved quality of life and some he-
modynamic parameters. The first published long-term
non-randomized study on BiF was performed by
O’Donnell et al. [15]. He reported six patients in whom
BiF increased the walking distance in 6MWT, in-
creased LVEF, and resulted in the reduction in mi-
tral regurgitation and in NYHA functional class. Ad-
ditionally, these results were similar to changes ob-
served in 44 patients with traditional biventricular
CRT. Rocha et al. [18] compared the clinical, functional
and echocardiographic parameters between BiF and
BiV pacing mode. It was not a randomized study. They
found favorable results of resynchronization were
obtained with both techniques, with no significant dif-
ferences between the two groups, except for a high-
er QRS narrowing in the BiV group, and a trend of
a lower number or hospital admissions in the BiV
group. Bulava et al. [16, 19] in two published studies
examined echocardiographic parameters including
tissue Doppler imaging and invasive measurement of
hemodynamics in patients with BiF and BiV. They
found that dp/dt significantly increased in both pacing
modes compared to basal state, although higher val-
ues were obtained in BiV patients. Additionally, a sig-
nificant correlation was found between the distance
of the right ventricular apical and outflow tract leads
and percentage of dp/dt  (max) increase in idiopathic
dilated cardiomyopathy patients. They also assessed
that interventricular mechanical delay decreased in
BiF patients. They concluded that BiF improves left
ventricular hemodynamics by decreasing inter- and
intraventricular conduction delays.
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The BRIGHT was the first randomized, cross-
over study which assessed clinical status, NYHA
classification, 6MWT, Minnesota Quality-of-Life
Score and Hemodynamic status with LVEF in pa-
tients with BiF compared to a control group. All pa-
rameters were estimated prior to randomization and
after three months of follow-up. Bifocal pacing: sig-
nificantly improved LVEF, decreased NYHA clas-
sification from 2.8 ± 0.4 to 2.3 ± 0.7 (p < 0.007)
and the 6MWT improved from 372 ± 129 m to
453 ± 122 m (p < 0.05). Minnesota Living with
Heart Failure Scores decreased from 33 ± 20 to
24 ± 21 (p < 0.006). We found that, in cases where
biventricular CRT could not be achieved,
a right ventricular bifocal system seemed to be ben-
eficial for patients with heart failure. The results
showed a significant improvement in 6MWT and
objective hemodynamic parameters such as LVEF,
CO and reduction of mitral regurgitation in patients
after BiF implantation. These positive results re-
mained unchanged during the three month follow-up.
Our study is the first to assess bifocal pacing
in patients with end-stage heart failure: six of the
eight patients were in NYHA class IV. Compared
to the aforementioned studies, in which most pa-
tients were in NYHA III, in our cases bifocal pacing
provided an improvement in heart failure class in
all patients. Although in our patients, LVEF and
6MWT distance were lower compared to patients
in the BRIGHT study, during 3MFU we achieved
significant improvements in these parameters.
There are two possible causes for the improved
hemodynamic parameters through right ventricu-
lar bifocal pacing in the right ventricle. First of all,
BiF as well as CRT increase AV synchrony [35, 36].
Additionally, as published in the study by O’Donnell
et al. [15], BiF may decrease the degree of mitral
regurgitation, perhaps by provoking greater inter-
ventricular synchrony, particularly at the level of
the interventricular septum. Additionally Bulava
et al. [16, 19] showed that BiF can also decrease
interventricular dyssynchrony, suggesting that
leads should be placed in the right ventricle as far
as possible.
Limitations of the study
There is no comparison between BiF pacing
and RVOT and/or right ventricular apex. It would
be interesting to find out whether BiF gives better
hemodynamic and clinical results compared to only
RVOT pacing.
Conclusions
Right ventricular bifocal pacing in end-stage
heart failure patients with CRT indication and un-
successful left ventricular lead placement seems
a beneficial treatment for heart failure. Satisfacto-
ry hemodynamic and clinical results were observed
directly after BiF implantation and during the three
month follow-up.
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